Head-to-head · WeighScore
Bliv vs Invigor Medical
The verdict
Invigor Medical takes it — 86.1/100 to 60.9/100.
Invigor Medical grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. An established pharmacy operator with steady mid-market pricing and a broad catalog.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Bliv | Invigor Medical |
|---|---|---|
| WeighScore | 60.9/100 | 86.1/100 |
| Grade | C | B |
| Site position | #348 | #10 |
| Semaglutide | $116/mo (as low as, varies by plan and eligibility, compounded) | $199/mo |
| Tirzepatide | $199/mo (as low as, varies by plan and eligibility, compounded) | $339/mo |
| Coverage | Coverage not published | Not disclosed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #348 · C
FDAWarning letter issued to Bliv Wellness LLC dba Bliv in February 2026. See the FDA warning-letter database.
Strengths
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Where it loses points
- The advertised rates are 'as low as' figures footnoted 'based on plan structure and eligibility', and the plan selector sits behind the medical intake — the rate you are offered is not knowable before you hand over a medical history
- A $24.99 provider consultation fee is charged on top, and the refund policy deducts $200 for 'clinical coordination and account setup'
- The homepage advertises 'no long-term commitments or cancellation fees' while the terms require the membership fee to be paid 'in a single sum', call it non-refundable and refer to a 'Membership Term'
- The only figure smaller than the advertised rate is a $29 CareCredit/Klarna installment, which is a financing payment rather than the price of a month of medication
- FDA issued Bliv Wellness LLC dba Bliv a warning letter in February 2026; the letter is public in FDA's warning-letter database
Site position #10 · B
Strengths
- Mid-market pricing on both molecules
- Long-running operator
Where it loses points
- No explicit states list
- Compounded only
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.